Haohai Biology: Shareholders plan to reduce their holdings by no more than 0.4337% of the company's shares.

Haohai Life Sciences announced on February 12th that shareholder Lou Guoliang, with a 3.09% stake, plans to reduce his holdings by no more than 1 million shares of the company's stock through centralized bidding and block trading, representing no more than 0.4337% of the total share capital.